Increased NHE1 activity and/or expression has been shown in a variety of cancer types, including several breast cancer cell types [14], and has been proposed to be an early event in transformation especially via increased survival [15] and migratory/invasive properties [10]. Here, SLC9A1 is linked to breast carcinoma.